Cargando…

Radiosensitization by the novel DNA intercalating agent vosaroxin

PURPOSE: Vosaroxin is a first in class naphthyridine analog structurally related to quinolone antibacterials, that intercalates DNA and inhibits topoisomerase II. Vosaroxin is not a P-glycoprotein receptor substrate and its activity is independent of p53, thus evading common drug resistance mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Ira K, Graves, Christian, Kil, Whoon J, Kramp, Tamalee, Tofilon, Philip, Camphausen, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328287/ https://www.ncbi.nlm.nih.gov/pubmed/22369205 http://dx.doi.org/10.1186/1748-717X-7-26

Ejemplares similares

High throughput evaluation of gamma-H2AX
por: Avondoglio, Dane, et al.
Publicado: (2009)

Post-radiation increase in VEGF enhances glioma cell motility in vitro
por: Kil, Whoon Jong, et al.
Publicado: (2012)

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
por: Maachani, Uday B., et al.
Publicado: (2016)

Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models
por: Gravina, Giovanni Luca, et al.
Publicado: (2017)

Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization
por: Rath, Barbara H, et al.
Publicado: (2015)

Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
por: Buchanan, Ian M, et al.
Publicado: (2011)

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
por: Degorre, Charlotte, et al.
Publicado: (2021)

Detection of metabolic change in glioblastoma cells after radiotherapy using hyperpolarized (13)C‐MRI
por: Kawai, Tatsuya, et al.
Publicado: (2021)

CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I
por: Lehman, Stacey L., et al.
Publicado: (2022)

Translation Initiation Machinery as a Tumor Selective Target for Radiosensitization
por: Lehman, Stacey L., et al.
Publicado: (2021)

Therapies for acute myeloid leukemia: vosaroxin
por: Sayar, Hamid, et al.
Publicado: (2017)

Correlation of Plasma FL Expression with Bone Marrow Irradiation Dose
por: Sproull, Mary, et al.
Publicado: (2013)

Clinical and radiobiological consideration of cyclical hypofractionated radiation therapy also known as QUAD Shot for neglected skin cancer disfiguring the face of a non-compliant patient who was refusing surgery and protracted radiation therapy: case report
por: Kil, Whoon Jong, et al.
Publicado: (2019)

Modulation of miR-21 signaling by MPS1 in human glioblastoma
por: Maachani, Uday B., et al.
Publicado: (2015)

Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks
por: Hawtin, Rachael Elizabeth, et al.
Publicado: (2010)

Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia
por: Jamieson, Gene C., et al.
Publicado: (2016)

Preclinical models in radiation oncology
por: Kahn, Jenna, et al.
Publicado: (2012)

Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic
por: Shabason, Jacob E, et al.
Publicado: (2011)

LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1
por: Patel, Deven, et al.
Publicado: (2019)

DDRE-16. CYSTEINE IS AN ESSENTIAL AMINO ACID IN GLIOMAS
por: Ruiz-Rodado, Victor, et al.
Publicado: (2021)

Improving Radiation Response in Glioblastoma Using ECO/siRNA Nanoparticles Targeting DNA Damage Repair
por: Lee, Jennifer A., et al.
Publicado: (2020)

Glioblastoma cells have increased capacity to repair radiation-induced DNA damage after migration to the olfactory bulb
por: Degorre, Charlotte, et al.
Publicado: (2022)

A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia
por: Lancet, JE, et al.
Publicado: (2011)

Synthesis of Acridine-based DNA Bis-intercalating Agents
por: Moloney, Gerard P., et al.
Publicado: (2001)

Activation of cGAS-dependent antiviral responses by DNA intercalating agents
por: Pépin, Geneviève, et al.
Publicado: (2017)

Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
por: Daver, Naval, et al.
Publicado: (2017)

Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA
por: Wahba, Amy, et al.
Publicado: (2017)

DNA stretching in the nucleosome facilitates alkylation by an intercalating antitumour agent
por: Davey, Gabriela E., et al.
Publicado: (2010)

Attenuation of Cytotoxic Natural Product DNA Intercalating Agents by Caffeine
por: Hill, Gabrielle M., et al.
Publicado: (2011)

Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma
por: Shankavaram, Uma T, et al.
Publicado: (2012)

Astrocytes Enhance the Invasion Potential of Glioblastoma Stem-Like Cells
por: Rath, Barbara H., et al.
Publicado: (2013)

Rapid and Durable Symptom Palliation With Quad Shot Radiation Therapy to Nonosseous Metastatic/Recurrent Cancer in Elderly or Frail Patients in a Rural Community Clinic
por: Kil, Whoon Jong
Publicado: (2021)

Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
por: Ruiz-Rodado, Victor, et al.
Publicado: (2022)

Transition Metal Intercalators as Anticancer Agents—Recent Advances
por: Deo, Krishant M., et al.
Publicado: (2016)

A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
por: Gill, Martin R., et al.
Publicado: (2016)

Green and simple production of graphite intercalation compound used sodium bicarbonate as intercalation agent
por: Wang, Xin, et al.
Publicado: (2022)

Targeted genome mining for microbial antitumor agents acting through DNA intercalation
por: Zhao, Zhijie, et al.
Publicado: (2023)

Enhancement of the radiosensitivity of two human tumour cell lines by hexamethylene bisacetamide.
por: Bill, C. A., et al.
Publicado: (1990)

Corrigendum: A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
por: Gill, Martin R., et al.
Publicado: (2016)

StRAP: An Integrated Resource for Profiling High-Throughput Cancer Genomic Data from Stress Response Studies
por: Johnson, Seth, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7lhmn8n1tmc1qbr9318q9kih9r